Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹28,228.1
₹59,983 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,650.5
₹33,114 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹748.1
₹6,781 Cr
Pharmaceuticals & Drugs
₹430.6
₹6,777 Cr
Pharmaceuticals & Drugs
₹395.5
₹3,610 Cr
Pharmaceuticals & Drugs
₹305.3
₹3,417 Cr
Pharmaceuticals & Drugs
₹99.1
₹2,544 Cr
Pharmaceuticals & Drugs
₹773.5
₹441 Cr
Pharmaceuticals & Drugs
₹66.4
₹188 Cr
Pharmaceuticals & Drugs
₹35.5
₹173 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,650.5
₹4,973 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹430.6
₹4,108 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹395.5
₹2,477 Cr
Pharmaceuticals & Drugs
₹748.1
₹1,906 Cr
Pharmaceuticals & Drugs
₹305.3
₹707 Cr
Pharmaceuticals & Drugs
₹99.1
₹224 Cr
Pharmaceuticals & Drugs
₹35.5
₹111 Cr
Pharmaceuticals & Drugs
₹28,228.1
₹6,714 Cr
Pharmaceuticals & Drugs
₹773.5
₹316 Cr
Pharmaceuticals & Drugs
₹66.4
₹428 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,650.5
₹974 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹430.6
₹323 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹748.1
₹242 Cr
Pharmaceuticals & Drugs
₹395.5
₹199 Cr
Pharmaceuticals & Drugs
₹305.3
₹151 Cr
Pharmaceuticals & Drugs
₹99.1
₹144 Cr
Pharmaceuticals & Drugs
₹35.5
₹5 Cr
Pharmaceuticals & Drugs
₹28,228.1
₹1,509 Cr
Pharmaceuticals & Drugs
₹773.5
₹-15 Cr
Pharmaceuticals & Drugs
₹66.4
₹4 Cr

You may also like the below Video Courses